紫萸方治疗肾虚型多囊卵巢综合征不孕的临床研究

Clinical Study on Ziyu Prescription in the Treatment of Polycystic Ovary Syndrome Related Infertility of Kidney Deficiency

  • 摘要:
    目的 观察紫萸方治疗肾虚型多囊卵巢综合征不孕患者的临床疗效及对子宫内膜容受性的影响。
    方法 纳入肾虚型多囊卵巢综合征不孕患者120例,随机分为对照组、治疗组各60例,除去脱落病例、剔除病例,2组各完成56例。2组患者均给予来曲唑口服治疗,对照组加服中药安慰剂,治疗组加服中药紫萸方,2组疗程均为3个月经周期。以临床妊娠率及种植窗口期超声Salle评分为主要结局指标;以中医证候积分与血清雌二醇(Estradial,E2)、睾酮(Testosterone,T)、抗缪勒管激素(Anti-Müllerian hormone,AMH)、促黄体生产素(Luteinizing hormone,LH)、促卵泡生成素(Follicle-stimulating hormone,FSH)、胰岛素抵抗指数(Homeostatic model assessment of insulin resistance,HOMA-IR)、种植窗口期血清E2及孕酮(Progesterone,P)水平为次要结局指标。通过多因素Logistic回归、ROC曲线分析评估超声Salle评分与妊娠结局的相关性及预测能力,通过多重线性回归评估种植窗口期雌孕激素水平与超声Salle评分的关系。
    结果 治疗后,治疗组患者临床妊娠率及种植窗口期超声Salle评分显著高于对照组(P<0.05,P<0.01);治疗组患者中医证候总积分显著低于对照组(P<0.01);治疗组患者血清T、LH/FSH、HOMA-IR水平显著低于对照组(P<0.05,P<0.01);治疗组患者种植窗口期血清E2及P水平显著高于对照组(P<0.01)。多因素Logistic回归分析及ROC曲线分析提示超声Salle评分与妊娠率显著正相关且对妊娠结局有较高预测价值。多重线性回归分析发现种植窗口期超声Salle评分与E2、P之间存在线性关系,且P水平对其影响更甚。
    结论 紫萸方能提高肾虚型多囊卵巢综合征不孕患者的临床妊娠率,有效改善子宫内膜容受性,调节性激素及糖代谢水平,并降低中医证候积分,提升患者的生育生活质量。

     

    Abstract:
    OBJECTIVE To observe the clinical efficacy of Ziyu Prescription in the treatment of polycystic ovary syndrome related infertility of kidney deficiency and its effect on endometrial receptivity.
    METHODS A total of 120 patients with polycystic ovary syndrome related infertility of kidney deficiency were enrolled and randomly divided into a control group and a treatment group, with 60 cases in each group. After excluding dropout cases and excluded cases, 56 cases were completed in each group. The control group was treated with letrozole and placebo, while the treatment group was treated with letrozole and Ziyu Prescription. The treatment course of both groups was 3 menstrual cycles. The clinical pregnancy rate and ultrasound Salle score during the implantation window were the main outcome indicators. The traditional Chinese medicine (TCM) syndrome score and serum estradial (E2), testosterone (T), anti-Müllerian hormone (AMH), luteinizing hormone (LH), follicle-stimulating hormone (FSH), homeostatic model assessment of insulin resistance (HOMA-IR), serum E2 and progesterone (P) levels during the implantation window were used as secondary outcome indicators. Multivariate Logistic regression and ROC curve analysis were used to evaluate the effect and predictive ability of ultrasound Salle score on pregnancy outcome. Multiple linear regression was used to evaluate the effect of estrogen and progesterone levels during the implantation window on ultrasound Salle score.
    RESULTS After treatment, the clinical pregnancy rate and ultrasound Salle score during the implantation window in the treatment group were significantly higher than those in the control group (P < 0.05, P < 0.01). The total TCM syndrome score of the treatment group was significantly lower than that of the control group (P < 0.01); the serum T, LH/FSH, and HOMA-IR levels of the treatment group were significantly lower than those of the control group (P < 0.05, P < 0.01); the serum E2 and P levels of the treatment group were significantly higher than those of the control group during the implantation window period(P < 0.01). Multivariate Logistic regression analysis and ROC curve analysis showed that ultrasound Salle score was significantly positively correlated with pregnancy rate and had a high predictive value for pregnancy outcome. Multiple linear regression analysis found that there was a linear relationship between the ultrasound Salle score and E2 and P during the implantation window period, and the P level had a greater impact.
    CONCLUSION Ziyu Prescription can improve the clinical pregnancy rate of patients with polycystic ovary syndrome related infertility of kidney deficiency, effectively improve their endometrial receptivity, regulate the levels of sex hormones and glucose metabolism, reduce the TCM syndrome score, and improve the reproductive quality of patients.

     

/

返回文章
返回